Y10S 530/866
Involving immunoglobulin or antibody fragment
Official title: involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain
Y10S530/866 (Involving immunoglobulin or antibody fragment) appears on 601 US grants and 815 published applications in this corpus.
Search patents in Y10S- Granted patents
- 601
- Published applications
- 815
- Assignees
- 184
- Inventors
- 611
- Latest grant
- 31 Oct 2017
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 2 | 0 |
| 1982 | 6 | 0 |
| 1983 | 4 | 0 |
| 1984 | 6 | 0 |
| 1985 | 3 | 0 |
| 1986 | 4 | 0 |
| 1987 | 11 | 0 |
| 1988 | 10 | 0 |
| 1989 | 19 | 0 |
| 1990 | 26 | 0 |
| 1991 | 11 | 0 |
| 1992 | 15 | 0 |
| 1993 | 3 | 0 |
| 1994 | 5 | 0 |
| 1995 | 5 | 0 |
| 1996 | 6 | 0 |
| 1997 | 12 | 0 |
| 1998 | 23 | 0 |
| 1999 | 18 | 0 |
| 2000 | 14 | 0 |
| 2001 | 11 | 4 |
| 2002 | 17 | 33 |
| 2003 | 13 | 636 |
| 2004 | 11 | 32 |
| 2005 | 13 | 32 |
| 2006 | 39 | 15 |
| 2007 | 137 | 10 |
| 2008 | 92 | 6 |
| 2009 | 16 | 11 |
| 2010 | 12 | 6 |
| 2011 | 9 | 8 |
| 2012 | 8 | 4 |
| 2013 | 1 | 4 |
| 2014 | 6 | 1 |
| 2015 | 5 | 5 |
| 2016 | 3 | 3 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 2 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Amino acid sequences directed against cellular receptors for viruses and bacteria31 Oct 2017US 9,803,018 B2Ablynx N. V.
- Compositions and methods comprising binding proteins for adalimumab26 Apr 2016US 9,321,846 B2AbbVie Biotechnology Ltd.
- Polynucleotides encoding anti-CD20 antigen binding molecules with increased Fc receptor binding affinity and effector function29 Mar 2016US 9,296,820 B2Roche Glycart AG
- IgE CH3 peptide vaccine2 Feb 2016US 9,249,233 B2Pfizer Vaccines LLC
- Macaca fascicularis CCL1721 Apr 2015US 9,012,602 B2Janssen Biotech, Inc.
- Antigen binding molecules with increased fc receptor binding affinity and effector function12 Sep 2024US 2024/0301079 A1Roche Glycart AG
- Antigen binding molecules with increased fc receptor binding affinity and effector function6 Jul 2023US 2023/0212303 A1Roche Glycart AG
- Immune receptor analysis as diagnostic assay20 May 2021US 2021/0147929 A1Saint Louis University
- Antigen binding molecules with increased fc receptor binding affinity and effector function7 Jan 2021US 2021/0002382 A1Roche Glycart AG
- Soluble tumor necrosis factor receptor treatment of medical disorders6 Apr 2017US 2017/0096471 A1Immunex Corporation
Most cited
By later US patents
- Recombinant immunoglobin preparations4,785US 4,816,567 AGenentech, Inc. · 1989
- Single polypeptide chain binding molecules2,454US 4,946,778 AGenex Corporation · 1990
- Methods of producing immunoglobulins, vectors and transformed host cells for use therein609US 6,331,415 B1Genentech, Inc. · 2001
- Antibody conjugates for the delivery of compounds to target sites546US 4,671,958 ACytogen Corporation · 1987
- Biosynthetic antibody binding sites393US 5,132,405 ACreative BioMolecules, Inc. · 1992